Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Focus on data management and AI as Proact extends partnership with Nvidia

Proact continues to build on its capabilities as a customer partner for artificial intelligence (AI) projects. Proact’s data management excellence and elite partner status with global leader Nvidia creates new opportunities for customers to leverage modern AI systems.As data management specialists, Proact frequently faces customer requirements where the solution relies on advanced Artificial Intelligence (AI). Given their huge computing power, AI systems also need an infrastructure with matching performance, not least for organising large volumes of data and then create value from customer

BioArctic presents Nomination Committee

BioArctic presents Nomination Committee Stockholm, Sweden, October 13, 2020 – BioArctic's Annual General Meeting on May 7, 2020, adopted an instruction regarding the appointment of the Nomination Committee. Pursuant to this instruction the company shall have a Nomination Committee comprising one representative for each of the three principal shareholders in terms of votes, based on the information received from Euroclear Sweden AB on the last banking day in September 2020, as well as the Chairman of the Board (convener). September 30, 2020, the three largest shareholders were Demban

Handicare publishes preliminary earnings for the third quarter of 2020

Today, Handicare, a global market leader in stairlifts, publishes preliminary earnings for the third quarter of 2020 due to higher profit than market expectations.The preliminary third quarter results are expected to substantially exceed market expectations as a result of the successful establishment of a more competitive cost base as well as key stairlift markets recovering significantly after a period of lockdowns. Adjusted EBITA for the third quarter is anticipated to be EUR 6.1 million which represents a margin of 11.5%, compared to EUR 3.9 million (6.5%) for the corresponding period

HiQ invests in development in Skåne, Åsa Melvanius is new MD

Åsa Melvanius will be the new Managing Director of HiQ Skåne, where she will continue to build on HiQ’s successful operations in the Öresund region. “I’m very happy to welcome Åsa to our team in Skåne. She has an impressive track record and plenty of drive. Together with our fantastic consultants, sales reps, leaders and forward-thinking clients, she will help our business grow stronger in the region,” said Lars Stugemo, President and CEO of HiQ. Åsa Melvanius will take over as MD of HiQ’s subsidiary HiQ Skåne starting 10 January 2021, replacing Magnus Gudéhn, who has had the

SDRL – Cleansing announcement – restructuring process

Hamilton, Bermuda, September 13, 2020 - Certain of the new secured noteholders (the “NSNs”) approached Seadrill Limited (the “Company”) to discuss the possibility of extinguishing the outstanding NSNs in exchange for certain secured collateral. The attached slides (the “Cleansing Materials”) detail certain proposals and counter-proposals between the Company and the NSNs since August 30 2020. Discussions between the Company and the NSNs remain ongoing and the description of the Cleansing Materials does not purport to be complete and is qualified in its entirety by the complete text of the

Archer Limited – Amendment to financial covenants

Hamilton, Bermuda (October 13, 2020) Archer Limited (“Archer” or the “Company”) is pleased to announce that its syndicate banks (the “Lenders”) have agreed to certain amendments to the USD 580 million multicurrency term and revolving credit facility (the "Facility") maturing October 1, 2023 (the “Maturity”). The amendments are conditioned on satisfactory documentation. To increase the Company’s financial flexibility, the Lenders have agreed to certain amendments in the Facility, including a temporary increase in the net interest bearing debt to 12 months rolling EBITDA covenant (“

Fiskars reinstates guidance for 2020, expects the comparable EBITA to increase from 2019

Fiskars CorporationInsider InformationOctober 13, 2020 at 08:30 (EEST) Fiskars reinstates guidance for 2020, expects the comparable EBITA to increase from 2019On March 19, Fiskars Corporation withdrew its guidance on the outlook for 2020 due to the impact of the COVID-19 pandemic. Fiskars now reinstates its guidance on the outlook for 2020 and expects the comparable EBITA to increase from 2019. “Despite the challenging operating environment, the company’s performance during the third quarter has been positive, especially towards the end of the quarter. Favorable weather

Nixu Corporation: CEO’s review for Q3 2020

Nixu Corporation Stock Exchange Release, October 13, 2020 at 8:30 am EESTNixu Corporation’s unaudited revenue for July–September 2020 increased organically by 3.6% from the corresponding period of the previous year and amounted to EUR 11.1 million (Q3/2019: EUR 10.7 million). EBITDA amounted to EUR 1,016 thousand (Q3/2019: EUR –599 thousand). Nixu Corporation revenue 1-9/2020 is EUR 38.7 million and EBITDA EUR 1,076 thousand. (1-9/2019: revenue EUR 36.4 million and EBITDA 1,376 thousand). In March 2020, Nixu withdrew its financial guidance due to the exceptional uncertainty caused by

SMART-TRIAL's co-founder clears up myths about the GDPR to help MedTech companies with new MDR compliance

Jon I. Bergsteinsson, a MedTech expert and co-founder of SMART-TRIAL, will be debunking myths about the EU General Data Protection Regulation (GDPR) and Medical Device Clinical Trials at this year's MedTech Summit. Jon will present a new talk called “Common Pitfalls in Medical Device Studies - How to Mitigate and Prevent Them” which will be streamed live on Wednesday the 14th of October as a part of the Clinical Evaluations and Investigations conference stream.With 7 years of experience helping MedTech companies with clinical data collection, Jon has observed several pitfalls repeatedly in

Correction: Nixu Corporation's Half-Year Financial Report 2020

Nixu Corporation Stock Exchange Release, October 13, 2020 at 8:25 am EESTNixu corrects its Half-Year Financial Report for January 1–June 30, 2020. The company has noticed a need to adjust the timing of recognition of certain technology resale client agreements of the Denmark market area. The adjusted revenue is recognized in later reporting periods. This change has no effect on the company’s cash flows. For January 1–June 30, 2020 Nixu Group’s revenue was EUR 27,655 thousand (previously reported: EUR 29,218 thousand). For January 1–June 30, 2020 Nixu’s EBITDA was EUR 59 thousand (

Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer

· The pre-defined disease control efficacy threshold in part 1 in the colorectal cancer cohort has been met · The colorectal expansion cohort has been opened for recruitment of 14 additional patients · The pre-defined disease control efficacy threshold in ovarian cancer was not met and this cohort will be closed for enrollmentOslo, Norway, 13 October 2020 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today announced that the colorectal cancer cohort in part 1 of the ONCOS-102 and durvalumab trial

Savon Kuljetus uses biogas-powered delivery vehicles to expand its operations to the Greater Helsinki Area

Savon Kuljetus Oy is to start using ten biogas-powered delivery vehicles from the end of the year. The company earlier mostly operated in the Savo region but with new gas-power vehicles can expand its operations to the Greater Helsinki Area.Savon Kuljetus Oy, a transport and infrastructure business, has ordered ten gas-powered delivery vehicles The company has committed to using only biogas to fuel its new delivery vehicles. These new vehicles will deliver parceled goods mostly in the Greater Helsinki Area but will also operate in Kotka, Lahti and Hämeenlinna. “We want to be a leader in

A.S.Helsingö’s Instant Collection offers sideboards with fast delivery

A.S.Helsingö’s new Instant Collection is the answer for those who enjoy the convenience of a curated collection with fast delivery. The collection consists of our most popular sideboards – delivered to the customer in approximately 7 days. A.S.Helsingö’s personal and customizable storage furniture are made to order, but the Instant Collection offers our most beloved and popular sideboards with immediate shipment from our warehouse to the customer.   A.S.Helsingö  launches a selection of its favorite sideboards with extra fast delivery time. The

Neste expands mobile payment services to the Baltics ‒ According to Neste’s survey, one in four Finns has made mobile payments more actively this year

Neste Corporation, Press release, 13 October, 2020 at 8 a.m. (EET) Neste expands mobile payment services to the Baltics. The mobile application, Neste App, launched on the Finnish market in 2017, was introduced to Estonia and Latvia earlier this year. During October 2020, it will also be made available for Lithuanian motorists.  “The ease of making payments is playing an increasingly central role in the customer experience today. For example, with the Neste App, you can conveniently pay for refuelling and car washing without getting out of the car. Mobile payments have

World’s largest exporters fail to punish bribery in foreign markets

Report finds enforcement against foreign bribery shockingly low among half of G20 countriesFewer of the world’s biggest exporters are actively investigating and punishing companies paying bribes abroad, according to a new report released today by Transparency International. Read the report  Exporting Corruption 2020: Assessing Enforcement of the OECD Anti-Bribery Convention, finds that active enforcement against foreign bribery significantly decreased since 2018. The share of global exports from countries that actively enforce

BreastScreen NSW first in Australia to improve patient care with secure image sharing service from Sectra

Sydney, Australia – October 13, 2020 – BreastScreen New South Wales (NSW) has now gone live with international medical imaging IT and cybersecurity company Sectra’s  (STO: SECT B) cloud service for medical image sharing and collaboration. The service will facilitate secure medical image and information sharing with clients, surgeons, private radiology providers and other service providers in the BreastScreen organization. Remote image sharing will improve efficiency by eliminating the need to handle CDs, and minimize the risks associated with new and unnecessary radiology

Major shareholder announcement – BlackRock, Inc.’ s holding as at 8 October 2020

Vestas Wind Systems A/S, Aarhus, 12 October 2020Company announcement No. 32/2020   Major shareholder announcement – BlackRock, Inc.’s holding as at 8 October 2020 Pursuant to Section 30 of the Danish Capital Markets Act, Vestas Wind Systems A/S hereby informs that the company has been notified on 12 October 2020 that BlackRock, Inc., Wilmington, DE, USA, on 8 October 2020 had a holding of voting rights and share capital attached to the Vestas share corresponding to a position of 5.03 percent (previously 4.97 percent) of the total share capital in Vestas Wind Systems A/S.

Reduced sales due to covid-19

(Figures in brackets refer to the corresponding period of last year.) In most countries BioGaia's sales depend on doctors and pharmacists recommending their patients to use BioGaia's products. Due to the covid-19 situation, BioGaia's distributors' sales forces have not to the same extent as before been able to visit doctors and pharmacy staff in most markets where BioGaia operates. BioGaia therefore estimates that sales and earnings will be negatively affected both in quarter three and quarter four 2020. For the third quarter, sales are estimated to amount to approximately SEK 132 (

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 12.10.2020

United Bankers Corporation NOTIFICATION 12.10.2020 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 12.10.2020 Date 12.10.2020Exchange transaction BuyShare class UNIAVAmount 497Average price/share 9.2000 EURHighest price/share 9.2000 EURLowest price/share 9.2000 EURTotal price 4,572.40 EUR The shares held by United Bankers Corporation on 12.10.2020: UNIAV 21,299   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

Financial and operational update about the diabetes vaccine Diamyd[®]

Diamyd Medical’s current cash position of approximately SEK 180 million supports all ongoing operational activities for the financial year as well as start-up activities for a confirmatory phase III trial with the diabetes vaccine Diamyd[® ]in both the United States and Europe that is currently being planned. The Company is also pursuing potential partnerships for future commercialization alongside discussions with potential investors,  with the aim of fully financing the execution of the phase III program, the manufacturing program, and market launch as well as to facilitate pivotal

Continued studies with Pelvipharm to generate knowledge about treatment times, doses and Libiguin’s® mechanism of action

Press release: Uppsala, October 12, 2020. As previously reported, Dicot has conducted the first study in collaboration with Pelvipharm SAS with tests in a model for erectile function in normal rats. Satisfactory results showed that treatment with Dicot's substance Libiguin® has a dose-dependent effect in these animals. Likewise, Sildenafil (Viagra), the reference compound routinely used in this model, displayed the expected effect on erectile functions of normal rats.In this first study, the experimental animals were dosed in a similar way that was originally used in folk medicine use in

NENT Group teams with Adi Hasak and Anna Friel to create ‘The Box’

· English-language production created by Adi Hasak (NBC’s ‘Shades of Blue’; ‘Eyewitness’) · Anna Friel’s first series since International Emmy-winning role in ‘Marcella’ · NENT Group to premiere at least 30 original productions in 2020 Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, will partner with Adi Hasak, creator of the hit NBC series ‘Shades of Blue’ and the award-winning ‘Eyewitness’, and International Emmy winner Anna Friel on the supernatural anthology original series ‘The Box’. The English-language show will premiere exclusively on

Nordic Paper publishes prospectus and price range for its initial public offering on Nasdaq Stockholm

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.For complete press release, please refer to the link: https://www.nordic-paper.com/investors/ipo-confirm For further information, please contact: Anita Sjölander, CEO of Nordic Paper Holding AB (publ)Tel: +46

Notification under Chapter 9, Section 10 of the Finnish Securities Market Act: holdings of Société Générale S.A. in Neste Corporation exceeded 5%

Neste Corporation, Stock Exchange Release, 12 October 2020 at 6 p.m. (EET) Neste Corporation has today received a notification under Chapter 9, Section 10 of the Finnish Securities Market Act (FSMA). According to the notification, the holdings of Société Générale S.A. in Neste Corporation have on 8 October 2020 exceeded 5% of the total number of shares and voting rights of Neste Corporation. According to the notification received by Neste Corporation, the holdings of Société Générale S.A. in Neste Corporation on 8 October 2020 amounted to a total of 39,644,533 shares, corresponding to

There are no items matching the current filter
There are no more items matching the current filter
Back to top